The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FOLFOXIRI ± molecular targeting agent (bevacizumab or panitumumab) for conversion from unresectable to resectable in the advanced/recurrent colorectal cancer.
 
Kodai Takemori
No Relationships to Disclose
 
Kazuma Kobayashi
No Relationships to Disclose
 
Yusuke Inoue
No Relationships to Disclose
 
Satomi Okada
No Relationships to Disclose
 
Toshiyuki Adachi
No Relationships to Disclose
 
Akihiko Soyama
No Relationships to Disclose
 
Tomohiko Adachi
No Relationships to Disclose
 
Kengo Kanetaka
No Relationships to Disclose
 
Susumu Eguchi
No Relationships to Disclose